480 related articles for article (PubMed ID: 8842438)
1. Effects of theophylline and rolipram on leukotriene C4 (LTC4) synthesis and chemotaxis of human eosinophils from normal and atopic subjects.
Tenor H; Hatzelmann A; Church MK; Schudt C; Shute JK
Br J Pharmacol; 1996 Aug; 118(7):1727-35. PubMed ID: 8842438
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of non-selective and selective phosphodiesterase inhibitors on human eosinophil functions.
Hatzelmann A; Tenor H; Schudt C
Br J Pharmacol; 1995 Feb; 114(4):821-31. PubMed ID: 7539697
[TBL] [Abstract][Full Text] [Related]
3. Selective inhibition of phosphodiesterase type IV suppresses the chemotactic responsiveness of rat eosinophils in vitro.
Alves AC; Pires AL; Cruz HN; Serra MF; Diaz BL; Cordeiro RS; Lagente V; Martins MA
Eur J Pharmacol; 1996 Sep; 312(1):89-96. PubMed ID: 8891583
[TBL] [Abstract][Full Text] [Related]
4. In vitro pharmacology of the novel phosphodiesterase type 4 inhibitor, CP-80633.
Cohan VL; Showell HJ; Fisher DA; Pazoles CJ; Watson JW; Turner CR; Cheng JB
J Pharmacol Exp Ther; 1996 Sep; 278(3):1356-61. PubMed ID: 8819523
[TBL] [Abstract][Full Text] [Related]
5. Possible role of cyclic AMP phosphodiesterases in the actions of ibudilast on eosinophil thromboxane generation and airways smooth muscle tone.
Souness JE; Villamil ME; Scott LC; Tomkinson A; Giembycz MA; Raeburn D
Br J Pharmacol; 1994 Apr; 111(4):1081-8. PubMed ID: 8032594
[TBL] [Abstract][Full Text] [Related]
6. Suppression of eosinophil function by RP 73401, a potent and selective inhibitor of cyclic AMP-specific phosphodiesterase: comparison with rolipram.
Souness JE; Maslen C; Webber S; Foster M; Raeburn D; Palfreyman MN; Ashton MJ; Karlsson JA
Br J Pharmacol; 1995 May; 115(1):39-46. PubMed ID: 7647982
[TBL] [Abstract][Full Text] [Related]
7. Suppression of human eosinophil respiratory burst and cyclic AMP hydrolysis by inhibitors of type IV phosphodiesterase: interaction with the beta adrenoceptor agonist albuterol.
Dent G; Giembycz MA; Evans PM; Rabe KF; Barnes PJ
J Pharmacol Exp Ther; 1994 Dec; 271(3):1167-74. PubMed ID: 7996422
[TBL] [Abstract][Full Text] [Related]
8. Investigation of the inhibitory effects of PGE2 and selective EP agonists on chemotaxis of human neutrophils.
Armstrong RA
Br J Pharmacol; 1995 Dec; 116(7):2903-8. PubMed ID: 8680723
[TBL] [Abstract][Full Text] [Related]
9. Effects of agents which elevate cyclic AMP on guinea-pig eosinophil homotypic aggregation.
Teixeira MM; Rossi AG; Giembycz MA; Hellewell PG
Br J Pharmacol; 1996 Aug; 118(8):2099-106. PubMed ID: 8864548
[TBL] [Abstract][Full Text] [Related]
10. Requirement of additional adenylate cyclase activation for the inhibition of human eosinophil degranulation by phosphodiesterase IV inhibitors.
Ezeamuzie CI
Eur J Pharmacol; 2001 Apr; 417(1-2):11-8. PubMed ID: 11301054
[TBL] [Abstract][Full Text] [Related]
11. Elevated intracellular cyclic AMP inhibits chemotaxis in human eosinophils.
Kaneko T; Alvarez R; Ueki IF; Nadel JA
Cell Signal; 1995 Jul; 7(5):527-34. PubMed ID: 8562314
[TBL] [Abstract][Full Text] [Related]
12. Stereospecificity of rolipram actions on eosinophil cyclic AMP-specific phosphodiesterase.
Souness JE; Scott LC
Biochem J; 1993 Apr; 291 ( Pt 2)(Pt 2):389-95. PubMed ID: 8387267
[TBL] [Abstract][Full Text] [Related]
13. Possible Contribution of Prostaglandin E2 to the antiproliferative effect of phosphodiesterase 4 inhibitors in human mononuclear cells.
Banner KH; Hoult JR; Taylor MN; Landells LJ; Page CP
Biochem Pharmacol; 1999 Nov; 58(9):1487-95. PubMed ID: 10513992
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of PAF-induced expression of CD11b and shedding of L-selectin on human neutrophils and eosinophils by the type IV selective PDE inhibitor, rolipram.
Berends C; Dijkhuizen B; de Monchy JG; Dubois AE; Gerritsen J; Kauffman HF
Eur Respir J; 1997 May; 10(5):1000-7. PubMed ID: 9163638
[TBL] [Abstract][Full Text] [Related]
15. Blockade of LTC4 synthesis caused by additive inhibition of gIV-PLA2 phosphorylation: Effect of salmeterol and PDE4 inhibition in human eosinophils.
Meliton AY; Muñoz NM; Liu J; Lambertino AT; Boetticher E; Myo S; Myou S; Zhu X; Johnson M; Leff AR
J Allergy Clin Immunol; 2003 Aug; 112(2):404-10. PubMed ID: 12897749
[TBL] [Abstract][Full Text] [Related]
16. Protein kinase C inhibition enhances platelet-activating factor-induced eicosanoid production in human eosinophils.
Dent G; Muñoz NM; Rühlmann E; Zhu X; Leff AR; Magnussen H; Rabe KF
Am J Respir Cell Mol Biol; 1998 Jan; 18(1):136-44. PubMed ID: 9448055
[TBL] [Abstract][Full Text] [Related]
17. The effect of salmeterol and nimesulide on chemotaxis and synthesis of PAF and LTC4 by human eosinophils.
Tool AT; Mul FP; Knol EF; Verhoeven AJ; Roos D
Eur Respir J Suppl; 1996 Aug; 22():141s-145s. PubMed ID: 8871060
[TBL] [Abstract][Full Text] [Related]
18. Phosphodiesterase and cyclic adenosine monophosphate-dependent inhibition of T-lymphocyte chemotaxis.
Hidi R; Timmermans S; Liu E; Schudt C; Dent G; Holgate ST; Djukanović R
Eur Respir J; 2000 Feb; 15(2):342-9. PubMed ID: 10706503
[TBL] [Abstract][Full Text] [Related]
19. Effects of SCA40 on human isolated bronchus and human polymorphonuclear leukocytes: comparison with rolipram, SKF94120 and levcromakalim.
Cortijo J; Villagrasa V; Navarrete C; Sanz C; Berto L; Michel A; Bonnet PA; Morcillo EJ
Br J Pharmacol; 1996 Sep; 119(1):99-106. PubMed ID: 8872362
[TBL] [Abstract][Full Text] [Related]
20. Characterization of guinea-pig eosinophil phosphodiesterase activity. Assessment of its involvement in regulating superoxide generation.
Souness JE; Carter CM; Diocee BK; Hassall GA; Wood LJ; Turner NC
Biochem Pharmacol; 1991 Jul; 42(4):937-45. PubMed ID: 1651083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]